Association of obesity on the outcome of critically ill patients affected by COVID-19.
Autors de IIS La Fe
Autors aliens a IIS La Fe
- Moreno, Gerard
- Diaz, Emili
- Ferre, Cristina
- Salgado, Melina
- Marin-Corral, Judith
- Estella, Angel
- Sole-Violan, Jordi
- Trefler, Sandra
- Socias, Lorenzo
- Borges-Sa, Marcio
- Restrepo, Marcos I
- Guardiola, Juan J
- Reyes, Luis F
- Albaya-Moreno, Antonio
- Berlanga, Alfonso Canabal
- Ortiz, Maria Del Valle
- Ballesteros, Juan Carlos
- Chinesta, Susana Sancho
- Laderas, Juan Carlos Pozo
- Gomez, Josep
- Bodi, Maria
- on behalf COVID-19/SEMCYUC Working group
Grups d'Investigació
Abstract
OBJECTIVE: To evaluate the impact of obesity on ICU mortality. DESIGN: Observational, retrospective, multicentre study. SETTING: Intensive Care Unit (ICU). PATIENTS: Adults patients admitted with COVID-19 and respiratory failure. INTERVENTIONS: None. PRIMARY VARIABLES OF INTEREST: Collected data included demographic and clinical characteristics, comorbidities, laboratory tests and ICU outcomes. Body mass index (BMI) impact on ICU mortality was studied as (1) a continuous variable, (2) a categorical variable obesity/non-obesity, and (3) as categories defined a priori: underweight, normal, overweight, obesity and Class III obesity. The impact of obesity on mortality was assessed by multiple logistic regression and Smooth Restricted cubic (SRC) splines for Cox hazard regression. RESULTS: 5,206 patients were included, 20 patients (0.4%) as underweight, 887(17.0%) as normal, 2390(46%) as overweight, 1672(32.1) as obese and 237(4.5%) as class III obesity. The obesity group patients (n?=?1909) were younger (61 vs. 65 years, p?<?0.001) and with lower severity scores APACHE II (13 [9-17] vs. 13[10-17, p?<?0.01) than non-obese. Overall ICU mortality was 28.5% and not different for obese (28.9%) or non-obese (28.3%, p?=?0.65). Only Class III obesity (OR?=?2.19, 95%CI 1.44-3.34) was associated with ICU mortality in the multivariate and SRC analysis. CONCLUSIONS: COVID-19 patients with a BMI?>?40 are at high risk of poor outcomes in the ICU. An effective vaccination schedule and prolonged social distancing should be recommended.
Copyright © 2023 Elsevier España, S.L.U. and SEMICYUC. All rights reserved.
Dades de la publicació
- ISSN/ISSNe:
- 2173-5727, 2173-5727
- Tipus:
- Article
- Pàgines:
- 142-154
- PubMed:
- 37923608
Medicina intensiva
Documents
- No hi ha documents
Filiacions
Filiacions no disponibles
Keywords
- COVID-19; Obesidad; Obesity; Prognosis; Pronóstico
Projectes associats
PRIMAGE. PREDICTIVE IN-SILICO MULTISCALE ANALYTICS TO SUPPORT CANCER PERSONALIZED DIAGNOSIS AND PROGNOSIS, EMPOWERED BY IMAGING BIOMARKERS.
Investigador Principal: LUIS MARTÍ BONMATÍ
826494 . COMISION EUROPEA . 2018
PerProGlio. Integrative Personal Omics Profiles in Glioblastoma Recurrence and Therapy Resistance.
Investigador Principal: LUIS MARTÍ BONMATÍ
AC18/00077 . COMISION EUROPEA . 2019
Multicentre prospective study of diagnostic accuracy for quantification by Magnetic Resonance multiparametric imaging of liver fibrosis, inflammation, steatosis, iron and vascular resistance.
Investigador Principal: LUIS MARTÍ BONMATÍ
PI19/00380 . INSTITUTO DE SALUD CARLOS III . 2020
Modulating the activity of genes controlling fat metabolism as a therapeutic strategy in Huntington disease.
Investigador Principal: RAFAEL VÁZQUEZ MANRIQUE
PI20/00114 . INSTITUTO DE SALUD CARLOS III . 2021